Price forming an orderly pullback contained by a down trend line (DTL). You want to see low volume within that wedge formation, with small down swings ideally.
This thread is about the technical setups I use day in/out to trade the markets 📒
1⃣Wedge break (WB)
2⃣Wedge break pullback (WBPB)
3⃣Breakout Retest short (BORS)
4⃣Breakout Retest Long (BORL)
5⃣Breakout 10ema PB (BO10PB)
6⃣Breakout 21ema PB (BO21PB)
That's my playbook 👇
Price forming an orderly pullback contained by a down trend line (DTL). You want to see low volume within that wedge formation, with small down swings ideally.
• DTL breakout ideally on higher than avrg. volume, OR
• PIVOT breakout daily high, OR
• Intraday PIVOT breakout H1 high
Stop Loss:
• Low Of Day (LOD), OR
• Recent swing low
After the WB, you often have a retest of the DTL, we then find support and follow through on the upside.
• PIVOT breakout ideally on higher than avrg. volume, OR
• PIVOT breakout daily high, OR
• Intraday PIVOT breakout H1 high
Stop Loss:
• Low Of Day (LOD), OR
• Recent swing low
After a base breakout, the BORS setup takes place when price comes back testing the BO pivot within a short period only.
• PIVOT breakout ideally on higher than avrg. volume, OR
• PIVOT breakout daily high, OR
• Intraday PIVOT breakout H1 high
Stop Loss:
• Low Of Day (LOD), OR
• Recent swing low
Sometimes we breakout with a lot of strength, but we pullback during a couple weeks back to the BO level in a wedge pattern.
You want to see low volume within that wedge formation, with small down swings ideally.
• DTL breakout ideally on higher than avrg. volume, OR
• PIVOT breakout daily high, OR
• Intraday PIVOT breakout H1 high
Stop Loss:
• Low Of Day (LOD), OR
• Recent swing low
When the b/o is powerful & buying pressure is sustained, we don't always get a breakout level retest. In that case we might only get a pullback to the 10dma. You want to wait for that lower risk entry to form, specially if you missed the initial b/o
• DTL breakout ideally on higher than avrg. volume, OR
• DTL breakout daily high (NEX=6.69$), OR
• Intraday DTL breakout H1 high, OR
• B/O swing high PIVOT b/o daily high, OR
• B/O swing high PIVOT b/o H1 high
Stop Loss:
• Low Of Day (LOD), OR
• Recent swing low
When the b/o is powerful & buying pressure is sustained, we don't always get a breakout level retest. In that case we might only get a pullback to the 21dma. You want to wait for that lower risk entry to form, specially if you missed the initial b/o
• DTL breakout ideally on higher than avrg. volume, OR
• DTL breakout daily high (DOCN=82.78$), OR
• Intraday DTL breakout H1 high, OR
• B/O swing high PIVOT b/o daily high, OR
• B/O swing high PIVOT b/o H1 high
Stop Loss:
• Low Of Day (LOD), OR
• Recent swing low
Every DAY I help new traders:
• A daily Market update & Focuslist Newsletter (Substack)
• A private Discord channel where you can learn live from me
Join over 1,200 traders taking their skills to the next level:
https://t.co/jg3QBEYkyG
More from All
You May Also Like
Moderna CEO Stephane Bancel was previously CEO of bioMerieux in France from 07-10.
Alain Merieux, who owns bioMerieux, was instrumental in the creation of the Wuhan Institute of Virology P4 Lab.
The same people who helped create the virus, also helped to create the vaccines...
Moderna partnered with French Pasteur Institute in 2015 to develop mRNA vaccine technology.
Pasteur Institute partnered with the Wuhan P4 Laboratory in 2017 along with the Merieux Foundation to study emerging viruses...
https://t.co/yFsHwrNYaK
https://t.co/9M5lydBKhM
Nobel prize winning scientist Luc Montagnier asserts that Sars-Cov-2 is man-made and originated from the Wuhan Institute of Virology.
Montagnier did extensive work with the Pasteur Institute in France which was partnered with the Wuhan P4.
Merieux Foundation & the Chinese government have worked together since 1965, and partnered to study emerging pathogens in Africa in 2015.
Their research included "PATHOGENS CARRIED BY BATS" that provoke respiratory diseases.
🚨🚨🚨
https://t.co/gVwpT0ssqI
Alain Merieux, who owns bioMerieux, was instrumental in the creation of the Wuhan Institute of Virology P4 Lab.
The same people who helped create the virus, also helped to create the vaccines...
Moderna partnered with French Pasteur Institute in 2015 to develop mRNA vaccine technology.
Pasteur Institute partnered with the Wuhan P4 Laboratory in 2017 along with the Merieux Foundation to study emerging viruses...
https://t.co/yFsHwrNYaK
https://t.co/9M5lydBKhM
Nobel prize winning scientist Luc Montagnier asserts that Sars-Cov-2 is man-made and originated from the Wuhan Institute of Virology.
Montagnier did extensive work with the Pasteur Institute in France which was partnered with the Wuhan P4.
Merieux Foundation & the Chinese government have worked together since 1965, and partnered to study emerging pathogens in Africa in 2015.
Their research included "PATHOGENS CARRIED BY BATS" that provoke respiratory diseases.
🚨🚨🚨
https://t.co/gVwpT0ssqI
